Evidence map›Paper›PMID 31460497›Full record

ArticleJournal of the American College of Clinical Pharmacy : JACCP2019

Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.

Omolola A Adeoye, Joel F Farley, Antoinette B Coe, Deborah L Pestka, Karen B Farris, Alan J Zillich, Margie E Snyder

Abstract read
In one paragraph

Article in Journal of the American College of Clinical Pharmacy : JACCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Medication Therapy Management: Current Challenges.Integrated pharmacy research & practice · 2020
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Omolola A AdeoyePurdue University College of Pharmacy, Indianapolis, IN.
Joel F FarleyUniversity of Minnesota College of Pharmacy, Minneapolis, MN.
Antoinette B CoeUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan.
Deborah L PestkaUniversity of Minnesota College of Pharmacy, Minneapolis, MN.
Karen B FarrisUniversity of Michigan College of Pharmacy, Ann Arbor, Michigan.
Alan J ZillichPurdue University College of Pharmacy, Indianapolis, IN.
Margie E SnyderPurdue University College of Pharmacy, Indianapolis, IN.

Funding

Institutional Career Development CoreKL2TR002241 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELLINGROD, VICKI L · 2017 to 2021
$6.9M
Indiana Clinical and Translational Sciences InstituteTL1TR001107 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$2.0M
An Evaluation of the Spread and Scale of PatientToc from Primary Care to Community Pharmacy Practice for the Collection of Patient-Reported OutcomesR18HS025943 · AHRQ · PURDUE UNIVERSITY · PI SNYDER, MARGIE E · 2019 to 2021
$1.4M
Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered Medication Therapy ManagementR21HS025005 · AHRQ · PURDUE UNIVERSITY · PI SNYDER, MARGIE E · 2016 to 2017
$296k
AHRQ HHS R18 HS025943AHRQ HHS R21 HS025005NCATS NIH HHS KL2 TR002241NCATS NIH HHS TL1 TR001107
6 · The paper itself

Abstract

introductionThe Medicare Part D medication therapy management (MTM) program positions pharmacists to optimize beneficiaries' medications and improve care. Little is known regarding Part D MTM delivery by community pharmacists and other pharmacist provider types.

objectivesTo (1) characterize Medicare Part D MTM delivery by community pharmacists, (2) compare MTM delivery by community pharmacists to other pharmacists, and (3) generate hypotheses for future research.

methodsA descriptive cross-sectional study using merged data from a 20% random sample of Medicare beneficiary enrollment data with a 100% sample of recently available 2014 Part D MTM files was conducted. Andersen's Behavioral Model was applied to describe MTM delivery across beneficiary characteristics. Descriptive and bivariate statistics were used to compare delivery of MTM between community and other pharmacist providers.

resultsAmong beneficiaries sampled, community pharmacists provided comprehensive medication reviews (CMRs) to 22% (n=26,337) of beneficiaries receiving at least one CMR. Almost half (49.4%) were provided face-to-face. Across pharmacist cohorts, median days to CMR offer of post-MTM program enrollment were within the 60-day policy requirement. The community pharmacist cohort had fewer days from CMR offer to receipt (median 47 days). Community pharmacists provided more medication therapy problem (MTP) recommendations (mean [SD] of 1.8 [3.5]; p<0.001), but resolved less MTPs (0.2 [0.7]; p<0.001), and most commonly served beneficiaries that were in the south but less in the west/northeast. Additionally, community pharmacists served a smaller proportion of black beneficiaries, yet a larger proportion of Hispanic beneficiaries (p<0.001).

conclusionCommunity pharmacists provided approximately one in five CMRs for MTM eligible beneficiaries in 2014, with CMRs occurring more quickly, resulting in more MTP recommendations, but resolving less MTPs than those provided by non-community pharmacists. Future research should explore geographic/racial-ethnic disparities in beneficiaries served and strategies to increase negligible MTP resolution by community pharmacists.

Indexed as

Community PharmacistsMedicare Part DMedication Therapy Management

Identifiers

PMID31460497
PMCPMC6711192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.